Weight-loss medications appear to slow biological aging, according to new research
Novo Nordisk and Eli Lilly find their GLP-1 weight-loss drugs may slow biological aging by two to three years, per aging-clock studies.
CLAY TRIBUNE / THE ARCHIVE
Tag: GLP-1
GLP-1 Prescriptions for Obese Children Up 310-Fold — But Severe Cases Often Miss Out
A transplant surgeon studies GLP-1 prescriptions for children with obesity, finding reassurance amid alarm over the system's neglect.
STAT’s Pharmalittle: GLP-1s Become Lifestyle Drugs, Merck and Daiichi Withdraw Lung Cancer Application
A weekly roundup of health headlines: GLP-1 drugs shift from medicine to lifestyle, Merck and Daiichi pull back on cancer, and more.
Novo Nordisk Names Five Multi-Blockbuster Targets and Promises Revenue Growth on Par With Big Pharma
Novo Nordisk promises five blockbuster drugs by 2030 and says it will sell medicines more like consumer goods.
Ozempic Changes Your Body — But Not Your Job or Your Chances of Marriage
A study finds Ozempic and GLP-1 drugs improve physical health but show no measurable effect on mental health, jobs, or marriages.